1. Home
  2. XERS vs LIND Comparison

XERS vs LIND Comparison

Compare XERS & LIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XERS
  • LIND
  • Stock Information
  • Founded
  • XERS 2005
  • LIND 1979
  • Country
  • XERS United States
  • LIND United States
  • Employees
  • XERS N/A
  • LIND N/A
  • Industry
  • XERS Biotechnology: Pharmaceutical Preparations
  • LIND Transportation Services
  • Sector
  • XERS Health Care
  • LIND Consumer Discretionary
  • Exchange
  • XERS Nasdaq
  • LIND Nasdaq
  • Market Cap
  • XERS 752.7M
  • LIND 618.2M
  • IPO Year
  • XERS 2018
  • LIND N/A
  • Fundamental
  • Price
  • XERS $5.49
  • LIND $12.29
  • Analyst Decision
  • XERS Strong Buy
  • LIND Strong Buy
  • Analyst Count
  • XERS 6
  • LIND 4
  • Target Price
  • XERS $6.25
  • LIND $15.75
  • AVG Volume (30 Days)
  • XERS 1.8M
  • LIND 293.6K
  • Earning Date
  • XERS 08-07-2025
  • LIND 08-04-2025
  • Dividend Yield
  • XERS N/A
  • LIND N/A
  • EPS Growth
  • XERS N/A
  • LIND N/A
  • EPS
  • XERS N/A
  • LIND N/A
  • Revenue
  • XERS $222,551,000.00
  • LIND $702,280,000.00
  • Revenue This Year
  • XERS $35.31
  • LIND $16.97
  • Revenue Next Year
  • XERS $19.65
  • LIND $9.34
  • P/E Ratio
  • XERS N/A
  • LIND N/A
  • Revenue Growth
  • XERS 29.88
  • LIND 18.74
  • 52 Week Low
  • XERS $2.10
  • LIND $6.76
  • 52 Week High
  • XERS $6.07
  • LIND $14.34
  • Technical
  • Relative Strength Index (RSI)
  • XERS 62.75
  • LIND 50.08
  • Support Level
  • XERS $4.94
  • LIND $11.37
  • Resistance Level
  • XERS $5.22
  • LIND $12.14
  • Average True Range (ATR)
  • XERS 0.22
  • LIND 0.50
  • MACD
  • XERS -0.01
  • LIND -0.13
  • Stochastic Oscillator
  • XERS 86.44
  • LIND 38.46

About XERS Xeris Biopharma Holdings Inc.

Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).

About LIND Lindblad Expeditions Holdings Inc.

Lindblad Expeditions Holdings Inc provides expedition cruising and adventure travel services. The company operates in two segments: Lindblad and Land Experiences, of which Lindblad generates the vast majority of its revenue. It offers itineraries that feature up-close encounters with wildlife, nature, history, and culture, as well as promote guest empowerment and interactivity. It operates expeditions on intimately-scaled ships and interaction between guests, crew, and the teams of scientists, naturalists, researchers, and photographers that participate in the expeditions. Lindblad operates a fleet of twelve owned expedition ships and five seasonal charter vessels under the Lindblad brand.

Share on Social Networks: